HC Wainwright & Co. Maintains Buy on VolitionRX, Lowers Price Target to $1
Benzinga Newsdesk 7 months ago
NewsPrice TargetAnalyst Ratings
HC Wainwright & Co. analyst Yi Chen maintains VolitionRX (AMEX:VNRX) with a Buy and lowers the price target from $1.5 to $1.
HC Wainwright & Co. analyst Yi Chen maintains VolitionRX (AMEX:VNRX) with a Buy and lowers the price target from $1.5 to $1.